Skip Navigation

Faculty Directory

Ryoko Susukida, PhD

  • Assistant Scientist

Departmental Affiliations

Contact Information

View Current Courses

Education

PhD, Johns Hopkins Bloomberg School of Public Health, 2017
PhD, National Graduate Institute for Policy Studies, 2013
BA, University of Tokyo, 2010

Honors and Awards

Phi Beta Kappa, Johns Hopkins Bloomberg School of Public Health (2017)

Fulbright Scholarship, Japan-U.S. Educational Commission (2013-2016)

The Lucy Shum Memorial Scholarship Award, Johns Hopkins Bloomberg School of Public Health (2015)

  • Substance use disorders
  • Health service use
  • Prevention
  • Psychiatric epidemiology
  • Health economics
  • Clinical trials
  • Observational study
  • Data harmonization
  • Generalizability

Selected publications:

  • Susukida, R., Crum, R. M., Stuart, E. A., Mojtabai, R. (2018). Generalizability of the Findings from a Randomized Controlled Trial of a Web-based Substance Use Disorder Intervention. The American Journal on Addictions, 27(3), 231-237.
  • Susukida, R., Crum, R. M., Hong, H., Stuart, E. A., Mojtabai, R. (2018). Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta?analytic studies. International Journal of Methods in Psychiatric Research, 27(4), e1609.
  • Susukida, R., Nishi, D., Kawashima, Y., Koido, Y., Mojtabai, R., Matsuoka, Y. J. (2018). Generalizability of Findings from a Randomized Controlled Trial of Fish Oil Supplementation for Attenuating Posttraumatic Stress Symptoms among Rescue Workers in Japan. Psychotherapy and Psychosomatics, 87(2), 114-115.
  • Susukida, R., Crum, R.M., Ebnesajjad, C., Stuart, E. A., Mojtabai, R. (2017). Generalizability of Findings from Randomized Controlled Trials: Application to the National Institute of Drug Abuse Clinical Trials Network. Addiction, 111(7), 1226-1234.
  • Susukida, R., Crum, R.M., Stuart, E. A., Ebnesajjad, C., Mojtabai, R. (2016). Assessing Sample Representativeness in Randomized Control Trials: Application to the National Institute of Drug Abuse Clinical Trials Network. Addiction, 111(7), 1226-1234.